Down But Not Out: Health Care Private Equity Deals Reached Nearly $90 Billion in 2022, The Industry's Second-biggest Year on Record

Bain & Company report shows resilience of health care in a downturn, citing biopharma and life sciences, value-based care and AI as areas for investors to watch

Bain & Company’s recently released 12th annual Global Healthcare Private Equity and M&A report reflects the continued resilience of the health care industry, with 2022 seeing near-record levels of health care dealmaking, in terms of both volume and value.

To continue reading,
become a free ALM digital reader

Benefits include:

  • Complimentary access to Consulting Magazine Online and digital edition
  • Bi-monthly digital newsletter delivered to your inbox
  • 1 free article* every 30 days to Consulting Magazine's sister publications
  • Exclusive discounts on events and publications produced by ALM

*May exclude premium content